Published in J Biol Chem on April 10, 1983
The Ah receptor and the mechanism of dioxin toxicity. Biochem J (1991) 1.22
Fatty acid oxidation in bone tissue and bone cells in culture. Characterization and hormonal influences. Biochem J (1987) 0.89
Synthesis of calbindin-D28K during mineralization in human bone marrow stromal cells. Biochem J (1998) 0.82
Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism. J Clin Invest (1988) 0.81
1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women. J Clin Invest (1987) 0.78
Hormonal regulation of vitamin D receptor levels and osteocalcin synthesis in human osteosarcoma cells. Calcif Tissue Int (1991) 0.75
The development of androgen-independent prostate cancer. Nat Rev Cancer (2001) 11.88
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum (1991) 7.94
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology (1993) 6.20
Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry (2001) 3.48
The cognitive neuroscience paradigm: a unifying metatheoretical framework for the science and practice of clinical psychology. J Clin Psychol (2001) 3.45
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med (2000) 3.26
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Seasonal fluctuation in the incidence of intracranial aneurysm rupture and its relationship to changing climatic conditions. J Neurosurg (1994) 2.26
Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest (1983) 2.25
Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med (1982) 2.25
The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease. Am J Gastroenterol (2001) 2.21
Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med (1984) 2.16
Cognitive neuroscience and the progress of psychological science: once more with feeling (and other mental constructs). J Clin Psychol (2001) 2.16
Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science (1988) 2.15
The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res (1996) 2.04
1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology (1981) 1.95
Distribution of a corticosteroid-binding protein in Candida and other fungal genera. J Gen Microbiol (1983) 1.86
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res (1994) 1.85
The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev (1999) 1.84
The Dictyostelium essential light chain is required for myosin function. Cell (1992) 1.82
Etiology of pyelonephritis: further evidence associating the production of experimental pyelonephritis with hemolysis in Escherichia coli. J Urol (1971) 1.70
Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology (1993) 1.68
Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis. Infect Immun (1984) 1.65
Subcellular mechanisms in the action of adrenal steroids. Am J Med (1972) 1.65
Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63
Circadian Rhythm in Amino Acid Uptake by Synechococcus RF-1. Plant Physiol (1991) 1.62
Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science (1986) 1.61
Experimental and clinical applications of fibrin glue. Plast Reconstr Surg (1991) 1.60
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
A corticosteroid binding protein and endogenous ligand in C. albicans indicating a possible steroid-receptor system. Nature (1981) 1.55
Typhlocolitis in NF-kappa B-deficient mice. J Immunol (2001) 1.53
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin Cancer Res (2001) 1.49
Tailored syringes as "bridging skeleton" in delayed sternal closure of complex congenital heart operation. Thorac Cardiovasc Surg (1993) 1.49
Estradiol binds to a receptor-like cytosol binding protein and initiates a biological response in Paracoccidioides brasiliensis. Proc Natl Acad Sci U S A (1983) 1.47
Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum (1986) 1.43
The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res (1997) 1.43
A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia. Clin Cancer Res (1998) 1.42
An estrogen-binding protein and endogenous ligand in Saccharomyces cerevisiae: possible hormone receptor system. Science (1982) 1.42
Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) J Urol (1998) 1.40
Post-traumatic stress disorder in primary-care settings: prevalence and physicians' detection. Psychol Med (2001) 1.40
1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res (2000) 1.39
Characterization of a unique corticosterone-binding protein in Candida albicans. J Biol Chem (1982) 1.37
Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res (2001) 1.36
Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J Clin Endocrinol Metab (1982) 1.36
Extensive polymorphism in the plasmodium vivax merozoite surface coat protein MSP-3alpha is limited to specific domains. Parasitology (2002) 1.32
Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone. Endocrinology (1978) 1.30
Different types of calcium channels. J Exp Biol (1986) 1.30
The goals and limitations of Israel's psychiatric case register. Psychiatr Serv (1999) 1.29
An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families. Proc Natl Acad Sci U S A (1989) 1.29
A unified model of eukaryotic chromosomes. Cytometry (1990) 1.28
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence. J Clin Oncol (1996) 1.28
Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol. Proc Natl Acad Sci U S A (1994) 1.27
Induction of mitosis in mature neurons in central nervous system by sustained depolarization. Science (1976) 1.24
The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res (1998) 1.23
Estrogens from plastic--are we being exposed? Endocrinology (1997) 1.22
Concordance between childhood injury diagnoses from two sources: an injury surveillance system and a physician billing claims database. Inj Prev (2005) 1.21
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest (1997) 1.17
Report from a forum on US heart allocation policy. Am J Transplant (2015) 1.17
Correlates of a perceived need for mental health assistance and differences between those who do and do not seek help. Soc Psychiatry Psychiatr Epidemiol (1999) 1.16
1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology (1986) 1.15
Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J Urol (2001) 1.14
Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486). J Clin Endocrinol Metab (2001) 1.14
MedEthEx Online: a computer-based learning program in medical ethics and communication skills. Teach Learn Med (2000) 1.14
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy. Cancer Chemother Pharmacol (1998) 1.14
Characterization of an estrogen-binding protein in the yeast Candida albicans. Endocrinology (1989) 1.13
A receptor-like binding macromolecule for 1 alpha, 25-dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem (1979) 1.12
Pink hypopyon caused by Klebsiella pneumonia. Eye (Lond) (2009) 1.11
Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology (1999) 1.11
Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304). Proc Natl Acad Sci U S A (1974) 1.11
Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology (1985) 1.11
Glucocorticoid receptors in rat kidney: the binding of tritiated-dexamethasone. Endocrinology (1973) 1.10
Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and in vitro studies. Anesth Analg (1991) 1.09
Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules. J Clin Oncol (1995) 1.09
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a. J Urol (1999) 1.08
Vitrectomy for endogenous Klebsiella pneumoniae endophthalmitis with massive subretinal abscess. Ophthalmic Surg Lasers (1997) 1.08
Bone and hormonal changes induced by skeletal unloading in the mature male rat. Am J Physiol (1999) 1.08
Acute angle-closure glaucoma resulting from spontaneous hemorrhagic retinal detachment in age-related macular degeneration: case reports and literature review. Jpn J Ophthalmol (2001) 1.08
Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors. Biochem Pharmacol (1974) 1.07
Measurement of 1,25-dihydroxyvitamin D3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites. Endocrinology (1987) 1.07
Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies. J Clin Endocrinol Metab (1980) 1.07
Cloning and expression of the gene from Candida albicans that encodes a high-affinity corticosteroid-binding protein. Proc Natl Acad Sci U S A (1993) 1.06
The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. J Clin Invest (1990) 1.06
Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol (2001) 1.05
Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology (1980) 1.05
Phase I and pharmacologic study of topotecan in patients with impaired renal function. J Clin Oncol (1996) 1.05
Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks. Cancer Res (1994) 1.04
Search for inherited susceptibility to radiation-associated meningioma by genomewide SNP linkage disequilibrium mapping. Br J Cancer (2011) 1.03
1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol (2000) 1.03
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃. Best Pract Res Clin Endocrinol Metab (2011) 1.02
Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. J Clin Endocrinol Metab (1989) 1.01
Characterization of an estrogen-binding protein in the yeast Saccharomyces cerevisiae. J Biol Chem (1984) 1.01
Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells. Endocrinology (1999) 1.01
Homologous up-regulation of the 1,25 (OH)2 vitamin D3 receptor in rats. Biochem Biophys Res Commun (1986) 1.01
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial. Cancer Treat Rep (1987) 1.00
Bone response to titanium alloy implants placed in diabetic rats. Int J Oral Maxillofac Implants (2000) 1.00
1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Endocrinology (1997) 0.99
Characterization of a cytoplasmic receptor-like binder for 1 alpha, 25-dihydroxycholecalciferol in rat intestinal mucosa. J Biol Chem (1979) 0.99